|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Recro Pharma (NASDAQ: REPH) through any online brokerage.
There are no as such competitors for Recro Pharma.
The latest price target for Recro Pharma (NASDAQ: REPH) was reported by Oppenheimer on 2020-05-12. The analyst firm set a price target for 12.00 expecting REPH to rise to within 12 months (a possible 306.78% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Recro Pharma (NASDAQ: REPH) is $2.95 last updated Today at 8:00:02 PM.
There are no upcoming dividends for Recro Pharma.
There is no upcoming split for Recro Pharma.